Ribosomes
December 15, 2025, 11:37 AM
Ribosome - Latest research and news | Nature
Revolutionizing disease treatment through the study of ribosomes | Stanford Report
Maria Barna and her team have developed techniques to map ribosomes at an unprecedented level of detail. The work could change how we understand and treat many diseases.
Changes to how ribosomes work can have drastic implications for human health. A few examples:
- Babies born with mutations in ribosome genes often have severe disease – some are missing entire organs or have bone malformations; others have serious forms of anemia.
- Conditions like Alzheimer’s and Parkinson’s are linked to clumps of misfolded proteins, which can result from faulty ribosome activity.
- Cancer cells often have hyperactive ribosomes to produce the proteins that tumors need for rapid growth.
New methods of studying ribosomes
Ribosomes are so tiny – and so plentiful in cells – that pinpointing the precise patterns in which they cluster has been difficult with standard microscopy. Barna’s team – led by former graduate students Zijian Zhang, PhD, and Adele Xu, MD, PhD – developed two cutting-edge techniques to study ribosomes at an unprecedented level of detail:
- RiboExM (ribosome expansion microscopy): With this technique, scientists embed cells in a special gel and expand them, making it possible to zoom in on ribosomes and see how they are arranged in much finer detail.
- ALIBi (optogenetic proximity labeling): Using light to activate molecular tags in specific, small areas of the cell, researchers can isolate and study ribosomes based on their location. This reveals what proteins are attached to them and what genetic messages they are reading.
“Previously we could see ribosomes as these black dots all over a cell but couldn’t really differentiate them,” Barna explained, “or see how any of them associated with each other or with structures in a cell.”
The ribosome is a large and complex molecular machine, found within all living cells, that serves as the primary site of biological protein synthesis (translation). Ribosomes link amino acids together in the order specified by messenger RNA (mRNA) molecules. Ribosomes consist of two major components — the small ribosomal subunit which reads the RNA, and the large subunit which joins amino acids to form a polypeptide chain. Each subunit is composed of one or more ribosomal RNA (rRNA) molecules and a variety of proteins. The ribosomes and associated molecules are also known as the translational apparatus. NB Ribozymes are inside the Ribosome. But the Ribozyme is historically a kind of Ribosome--go figure!
The sequence of DNA encoding for a protein may be copied many times into RNA chains of a similar sequence. Ribosomes can bind to an RNA chain and use it as a template for determining the correct sequence of amino acids in a particular protein. Amino acids are selected, collected and carried to the ribosome by transfer RNA (tRNA molecules), which enter one part of the ribosome and bind to the messenger RNA chain. The attached amino acids are then linked together by another part of the ribosome. Once the protein is produced, it can then 'fold' to produce a specific functional three-dimensional structure.
Protein synthesis from a mRNA template occurs on a ribosome, a nanomachine composed of proteins and ribosomal RNAs (rRNA). The ribosome is composed of two very large structural units. The smaller unit (termed 30S and 40S in bacteria and eukaryotes, respectively) coordinates the correct base pairing of the triplet codon on the mRNA with another small adapter RNA, transfer or tRNA, that brings a covalently connected amino acid to the site. Peptide bond formation occurs when another tRNA-amino acid molecule binds to an adjacent codon on mRNA. The tRNA has a cloverleaf tertiary structure with some intrastranded H-bonded secondary structure. The last three nucleotides at the 3' end of the tRNA are CpCpA. The amino acid is esterified to the terminal 3'OH of the terminal A by a protein enzyme, aminoacyl-tRNA synthetase.
Covalent amide bond formation between the second amino acid to the first, forming a dipeptide, occurs at the peptidyl transferase center, located on the larger ribosomal subunit (50S and 60S in bacteria and eukaryotes, respectively). The ribosome ratchets down the mRNA so the dipeptide-tRNA is now at the the P or Peptide site, awaiting a new tRNA-amino acid at the A or Amino site. The figure below shows a schematic of the ribosome with bound mRNA on the 30S subunit and tRNAs covalently attached to amino acid (or the growing peptide) at the A and P site, respectively.
A ribosomeis made from complexes of RNAs and proteins and is therefore a ribonucleoprotein. Each ribosome is divided into two subunits: a smaller subunit which binds to the mRNA pattern, and a larger subunit which binds to the tRNA and the amino acids. When a ribosome finishes reading an mRNA molecule, these two subunits split apart. Ribosomes are ribozymes, because the catalytic peptidyl transferase activity that links amino acids together is performed by the ribosomal RNA. (rRNA.)
Ribosomes from bacteria, archaea and eukaryotes (the three domains of life on Earth) differ in their size, sequence, structure, and the ratio of protein to RNA. The differences in structure allow some antibiotics to kill bacteria by inhibiting their ribosomes, while leaving human ribosomes unaffected. In bacteria and archaea, more than one ribosome may move along a single mRNA chain at one time, each "reading" its sequence and producing a corresponding protein molecule. The ribosomes in the mitochondria of eukaryotic cells functionally resemble many features of those in bacteria, reflecting the likely evolutionary origin of mitochondria.
The ribosome assembles polymeric protein molecules whose sequence is controlled by the sequence of messenger RNA molecules. This is required by all living cells and associated viruses.
A Site, P Site and E Site, are Aminoacyl (lets peptide bond form and Ribosome moves to right E site. P site is where Polypeptide forms. E Site Exit--see diagram above right.